Prosight Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-135,366
Closed -$3.26M – 41
2026
Q2
$3.26M Buy
+135,366
New +$3.54M 0.56% 26
2024
Q2
– Sell
-215,000
Closed -$5.97M – 55
2024
Q1
$5.97M Buy
+215,000
New +$5.97M 1.66% 18

Other funds holding PFE

Prosight Management's PFE Position: Q3 2026 in Review

Prosight Management sold out of Pfizer (PFE) in Q3 2026, closing a stake of 135,366 shares — an estimated $3.26M sold.

Prosight Management first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $5.97M in Q1 2024. 2,908 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Prosight Management reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Prosight Management sold 135,366 Pfizer shares in Q3 2026, an estimated $3.26M.
  • Prosight Management first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
  • Prosight Management's Pfizer position peaked at $5.97M in Q1 2024.
  • 2,908 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.